FB2026_03 , released September 17, 2026
Reference Report
Open Close
Reference
Citation
Smeir, E., Leberer, S., Blumrich, A., Vogler, G., Vasiliades, A., Dresen, S., Jaeger, C., Gloaguen, Y., Klose, C., Beule, D., Schulze, P.C., Bodmer, R., Foryst-Ludwig, A., Kintscher, U. (2021). Depletion of cardiac cardiolipin synthase alters systolic and diastolic function.  iScience 24(11): 103314.
FlyBase ID
FBrf0251939
Publication Type
Research paper
Abstract
Cardiolipin (CL) is a major cardiac mitochondrial phospholipid maintaining regular mitochondrial morphology and function in cardiomyocytes. Cardiac CL production includes its biosynthesis and a CL remodeling process. Here we studied the impact of CL biosynthesis and the enzyme cardiolipin synthase (CLS) on cardiac function. CLS and cardiac CL species were significantly downregulated in cardiomyocytes following catecholamine-induced cardiac damage in mice, accompanied by increased oxygen consumption rates, signs of oxidative stress, and mitochondrial uncoupling. RNAi-mediated cardiomyocyte-specific knockdown of CLS in Drosophila melanogaster resulted in marked cardiac dilatation, severe impairment of systolic performance, and slower diastolic filling velocity assessed by fluorescence-based heart imaging. Finally, we showed that CL72:8 is significantly decreased in cardiac samples from patients with heart failure with reduced ejection fraction (HFrEF). In summary, we identified CLS as a regulator of cardiac function. Considering the cardiac depletion of CL species in HFrEF, pharmacological targeting of CLS may be a promising therapeutic approach.
PubMed ID
PubMed Central ID
PMC8581512 (PMC) (EuropePMC)
Associated Information
Comments
Associated Files
Other Information
Secondary IDs
    Language of Publication
    English
    Additional Languages of Abstract
    Parent Publication
    Publication Type
    Journal
    Abbreviation
    iScience
    Title
    iScience
    ISBN/ISSN
    2589-0042
    Data From Reference
    Alleles (3)
    Genes (2)
    Human Disease Models (1)
    Transgenic Constructs (2)